Navigation Links
Women's Health Care Marketing Services Firm, Procare Health, Jumpstarts Success with Cloud-Based Veeva CRM
Date:10/22/2013

to find an agile CRM that could be easily adapted for each customer's unique needs. The solution also had to be fast to deploy, allowing Procare to provide its customers a fully functional system right out of the box that would be easily configurable to meet the specific needs of any client quickly. Procare deployed Veeva CRM in just four weeks, dramatically increasing its sales and marketing effectiveness.

"Veeva CRM is so intuitive and easy-to-use that our sales teams have quickly embraced it, even reps who are less familiar with modern technology," explained Gaslain. "They have been able to jump right in and start improving call efficiency. In fact, users are leveraging the system's powerful functionality effortlessly with less than one day's training."

Procare worked closely with both Veeva and Pharma Advisors, Veeva's local services partner, for the implementation. "Working with local, Spanish resources who speak in our native tongue helped to make the process smooth," remarked Gaslain. "All in all, we had wonderful support from the collective Veeva team. Everyone was highly responsive and committed to our success - which is exactly how we treat our customers."

About Procare Health

Procare Health (http://www.procarehealth.es) was founded in 2013 with the aim of developing as a strategic partner in the women's healthcare market, responding to increased demand as a result of the change of business model within the pharmaceutical industry.

Procare provides an innovative and distinctive business model for its strategic partners, which not only translates into significant cost savings and flexibility, but also adds value thanks to the expertise and know-how of the Procare team in the area of women's healthcare. The team is supported by the latest technological tools (including digitised promotional materials and cloud-based CRM systems), which help to position Procare as a key partner in
'/>"/>

SOURCE Veeva Systems
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
2. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
3. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
4. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
5. inVentiv Health Selected to Provide Sales Operations Support for Santarus
6. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
7. Hong Kong Department of Health to Combat Sudden Cardiac Arrest With Powerheart AEDs
8. Nations Best Health Care Organizations for Patient Satisfaction, Core Measures Honored by Press Ganey
9. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
10. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
11. Health Diagnostic Laboratory, Inc. Provides Largest Corporate Gift in Science Museum of Virginias History
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Clinical Laboratory, ... and Forecast 2015 to 2019 - Global Version" ... technical developments especially in the area of molecular ... dynamic, growing and evolving world market that is ...
(Date:5/5/2015)... SAN DIEGO , May 5, 2015 /PRNewswire/ ... today announced that David R. Parkinson , ... (NEA), has been appointed to the board of ... twenty years of experience in oncology clinical development, ... that resulted in global approvals of the cancer ...
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 Synedgen ... Nguyen, PhD as Regulatory Affairs Manager. , Dr. Nguyen ... an important juncture for the company as it moves ... drug products over the next two years. Dr. Nguyen ... of all the regulatory key documents that must be ...
(Date:5/4/2015)... , May 4, 2015 /PRNewswire/ - JSS Medical Research Inc., a ... today that it concluded the acquisition of Max Neeman International (MNI), ... Additional regional offices are located in Ahmedabad, Bangalore ... . Through a US subsidiary, a regional office is located ... expansion is supported by the recent equity investment transaction into JSS ...
Breaking Biology Technology:Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4Synedgen Announces the Appointment of Regulatory Affairs Manager 2JSS Medical Canada widens its global presence across Asia/Pacific region 2JSS Medical Canada widens its global presence across Asia/Pacific region 3JSS Medical Canada widens its global presence across Asia/Pacific region 4
... Genzyme,Corporation (Nasdaq: GENZ ) confirmed today that it ... BIVN ) at $5.60 in cash per,outstanding common share ... companies. Genzyme already owns approximately 22 percent of the,outstanding ... 100 percent of its preferred stock that carry a ...
... treatment option for asthma patients not fully controlled on ... ... Calif., Sept. 27 Dey, L.P., an,affiliate of Merck KGaA of ... tablets with its,marketing partner, Critical Therapeutics, Inc. (Nasdaq: CRTX ). ...
... 27 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ... on commercializing proprietary product candidates for the ... that data from,preclinical studies of ANX-514 (docetaxel ... of Cancer Research (AACR), National Cancer,Institute (NCI) ...
Cached Biology Technology:Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share 2Genzyme Affirms Purchase Price for Bioenvision at $5.60 Per Outstanding Share 3Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma 2Dey L.P. and Critical Therapeutics Launch Twice-Daily ZYFLO CR(TM) (Zileuton) Extended-Release Tablets for the Chronic Treatment of Asthma 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 2ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 3ADVENTRX to Present ANX-514 Preclinical Data at 2007 AACR-NCI-EORTC International Conference 4
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
(Date:3/31/2015)... NEW YORK , March 31, 2015  Elephant ... the "Company"), a global provider of Software Defined Network ... solutions, today announced total revenue of approximately $20.4 million ... to a restated $19.5 million for the year ended ... of calendar 2014, the Company had completed its multi-year ...
(Date:3/24/2015)... DUBLIN , Mar. 24, 2015 Research and ... addition of the "Global Iris Recognition Market 2015-2019" ... forecast the Global Iris Recognition market to grow at ... This report covers the present scenario and ... for the period 2015-2019. To calculate the market size, ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... of information, <a target="_blank" href="http://en.wikipedia.org/wiki/Nucleic_acid_sequence,">DNA sequences come ... identify, proof, and discard compromised molecular data has ... endeavor - one that everyone generating sequence data ... sequences for research purposes. "Many researchers find ...
... D.C. Georgetown Lombardi Comprehensive Cancer Center,s Stephen Byers, ... Cancer Institute to address a "provocative question.", The NCI,s ... 24 questions that, if answered, could lead to significant ... such as why obesity contributes to cancer risk ...
... for Autism Research at The Children,s Hospital of Philadelphia ... to identify early signs of autism spectrum disorders (ASD) ... (NIH) Autism Centers of Excellence (ACE) research program. CHOP ... for autism research, which is distributed across nine ACE ...
Cached Biology News:DNA sequences need quality time too - guidelines for quality control published 2Georgetown Lombardi researcher awarded 'Provocative Question' grant from NCI 2Georgetown Lombardi researcher awarded 'Provocative Question' grant from NCI 3CHOP’s Center for Autism Research receives five-year grant as an NIH Autism Center of Excellence 2
... G bind specifically to Fc regions of ... G conjugates are commonly used as affinity ... subtypes from serum, hybridoma ascites fluids, tissue ... reagents are also commonly used to capture ...
... SYS203 is a complete, flexible system ... small samples, as is frequently required ... designed around Instechs miniature Clark-style polarographic ... inch in diameter (3.2 mm), it ...
... the family of human cullin genes (CUL-1, -2, -3, ... cdc53 gene. Cullin-3 is proposed to be a part ... with cyclin E and targets it for ubiquitination, which ... an activator of cdk2, which leads the cell to ...
... the cost-effective solution for entry level imaging ... research imaging tasks, MetaVue enables time lapse, ... analysis. Compatibility with MetaMorphs extensive and ... has the power to drive motorized microscopes, ...
Biology Products: